ロード中...
Thioredoxin reductase: A novel, independent prognostic marker in patients with hepatocellular carcinoma
Here we found that hepatocellular carcinoma (HCC) patients with recurrence outcome and nonsurvivors had significantly increased thioredoxin reductase (TrxR) serum levels on reoperation (P < 0.0001 and P < 0.0001). Multivariate regression analysis adjusted for common risk factors showed that Tr...
保存先:
| 出版年: | Oncotarget |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Impact Journals LLC
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4627346/ https://ncbi.nlm.nih.gov/pubmed/25970775 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|